Mortality associated with influenza and respiratory syncytial virus in the United States.

By William W. Thompson, David K. Shay, Eric Weintraub, L. Brammer, Nancy J. Cox, Larry J. Anderson, Keiji Fukuda. Journal of the American Medical Association (JAMA), 2003

883 citations recorded by the source corpus.

Subfields: Epidemiology

View Paper: https://www.semanticscholar.org/paper/4f30cb40343b543804ccbf79b55f40cd7275e81d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Jacco Wallinga

Citations in the corpus

• Antibody response to influenza vaccination in the elderly: a quantitative review. (2006, background): “[1] Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, And son LJ, et al.”
• Causes, consequences, and reversal of immune system aging. (2013, neutral): “This is illustrated by increased vulnerability of individuals 70 years of age and older to influenza (1), a situation that is exacerbated by their poor response to vaccination (2–4).”
• Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. (2003, neutral): “Дети с бронхолегочной дисплазией 14,97 [11] 27–32 [9, 13] 17–100 [9, 13] 3,5–8,6 [10, 13]”
• Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. (2006, neutral): “5 (7-78) Florida 3/3 21 (11-50) Georgia 4/4 20 (12-35) Hawaii 6/14 18 (3-92) Idaho 5/5 44.”
• Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. (2009, neutral): “Asian/Pacific Islander 124 (14) 1 (13) 52 (19) 7 (8) 64 (13)”
• Influenza Virus Assembly and Budding (2011, neutral): “It is estimated that infection with seasonal strains of influenza virus results in the death of over 50,000 people per year (Thompson et al., 2003).”
• Containing pandemic influenza with antiviral agents. (2004, background): “In the United States, influenza epidemics usually occur during the winter months between November and April and are responsible for an average of 36,000 excess deaths per year (1).”
• Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, background): “Particularly vulnerable were persons with cardiopulmonary disease and persons aged 165 years, especially the “elderly elderly,” defined as persons 185 years of age [72].”
• Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009, background): “Risk for influenza-related death was highest among the oldest elderly, with persons aged ≥85 years 16 times more likely to die from an influenza-related illness than persons aged 65--69 years (6).”
• Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. (2010, methodology): “Future research should replicate and extend models that distinguish between deaths associated with influenza versus RSV (2).”
• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011, background): “During most influenza seasons, rates of serious illness and death are highest among persons aged ≥65 years, children aged <2 years, and persons of any age who have medical conditions that place them at increased risk for complications from influenza (3,4).”
• The Influenza Virus Resource at the National Center for Biotechnology Information (2007, background): “Each year in the USA, 11 more than 200,000 patients are admitted to hospitals because of influenza, and there are 12 approximately 36,000 influenza-related deaths (14).”